Our principal, Ms. Pauli Wong, was invited by HKUST to speak at their Entrepreneurship 101 Training Program on the topic of protecting start-ups through intellectual property. Her talk, titled “Patent 101 for Entrepreneurs and Start-Ups,” covered the fundamentals of IP, with a particular focus on patents. She highlighted often-overlooked aspects and shared invaluable tips to help start-up entrepreneurs avoid common pitfalls.

Pauli really enjoyed giving the talk and felt inspired by the positive feedback from the audience. She found it rewarding to share her knowledge about intellectual property and its importance for entrepreneurs. This experience has motivated her to give more presentations in the future, as she wants to reach more people and help them understand IP better.

On a side note, we want to wish the HKUST Entrepreneurship Center a happy 25th anniversary, which they are celebrating this week!




我們過去活動

Recommended Insights

Major and Exciting Changes to China’s Patent Law [Fourth Amendment to China's Patent Law]

2019年2月20日
Major changes are on the horizon for China’s Patent Law, which will see an overhaul in many areas as early as this year (2019). On January 4, 2019, the National People’s Congress in China published the latest draft of the Fourth Amendment to China’s Patent Law. Several draft amendments have been released for public comment […]

Compositions Limited by Use: A Cautionary Tale

2022年10月26日
Section 4.2.3, Part II Chapter 10 of the CNIPA’s Examination Guidelines (“Guidelines”) stipulates that if the specification only discloses one property or use of a composition, the composition claim shall be drafted as a “composition limited by the function or the use”. Furthermore, it specifically states that “most pharmaceutical claims shall be drafted as claims […]

China Top 10 Patent Re-Examination and Invalidation Cases of 2020 CNIPA Upholds Bayer’s Rivaroxaban Patent

2021年6月9日
The development of China’s approach to patents, especially those in the pharmaceutical and biotech space, has been fascinating to watch. Those of us who have practiced in the area for a long time have been frustrated by the Chinese patent office’s overly strict rules regarding patentability (e.g., high data support standard and refusal to consider […]

First ever Invalidation decision on an RNAi Invention patent in China

2023年12月4日
Decision on Examination of Request for Invalidation (No. 58530) In one of China’s Top 10 Patent Re-examination / Invalidation cases of 2022, an invalidation decision on a patent claiming Hepatitis B Virus (HBV) RNAi compositions (No. 58530) by the Patent Re-examination Board (the “Board”) sheds light on the standard for post filing data for rejections […]
Top crossarrow-right